Prospective real world data evaluation of clinical outcomes in metastatic hormone sensitive prostate cancer (MHSPC) patients treated as part of triplet therapy with darolutamide: UK multicenter RECOMMEND study.

Authors: Amit Bahl, Amarnath Challapalli, Prantik Das, Anand Sharma, Rajanee Bhana, Alison Jane Birtle, Dakshinmoorthy Muthukumar, Manreet Randhawa, Santhanam Sundar, Mark Prentice, Diletta Bianchini, Emily Renninson, Miguel CapoMir, Isabel Syndikus, Kamalram Thippu Jayaprakash, Thiraviyam Elumalai, Sarah Goodwin, Omi Parikh, Paul White, Emily Foulstone

Published: 2025-02-18

DOI: 10.1200/jco.2025.43.5_suppl.89

Source: Full article

Prospective real world data evaluation of clinical outcomes in metastatic hormone sensitive prostate cancer (MHSPC) patients treated as part of triplet therapy with darolutamide: UK multicenter RECOMMEND study.

Abstract